Vestagen develops and markets advanced performance textile products and technologies including Vestex®, the first in a new class of medical devices based on active barrier protective fabrics that are clinically proven to prevent or reduce the acquisition and retention of contaminants on clothing. Vestex garments are engineered to have robust liquid repellency and antimicrobial properties, along with breathability, comfort and durability. Based in Orlando, FL, Vestagen is led by CEO Ben Favret and a tenured team comprised of healthcare, biopharmaceutical, consumer products, apparel, textile manufacturing and regulatory experts. The team has extensive experience developing and launching brands and products in a wide variety of industries. Vestagen is backed by investors Advent Life Sciences, Alliance Healthcare Partners Group, founding investor V-Ten Capital and other private investors.
Type
Private
HQ
Orlando, US
Founded
2009
Size (employees)
22 (est)
Vestagen Technical Textiles was founded in 2009 and is headquartered in Orlando, US
Report incorrect company information

Key People/Management at Vestagen Technical Textiles

Uncas B. Favret

Uncas B. Favret

President and CEO
Brian Crawford

Brian Crawford

Chief Commercial Officer

Vestagen Technical Textiles Office Locations

Vestagen Technical Textiles has an office in Orlando
Orlando, US (HQ)
1301 W. Colonial Drive
Show all (1)
Report incorrect company information

Vestagen Technical Textiles Financials and Metrics

Summary Metrics

Founding Date

2009

Total Funding

$61.7 m

Latest funding size

$9.50 m

Time since last funding

8 months ago

Investors

Vestagen Technical Textiles's latest funding round in October 2017 was reported to be $9.5 m. In total, Vestagen Technical Textiles has raised $61.7 m
Show all financial metrics
Report incorrect company information